Scientific Interchange & Workshop


An Evolving Treatment Paradigm: ADCs in Non-Small Cell Lung Cancer

April 5th 2024

Exploring the Evolving Treatment Landscape and Therapeutic Challenges in Polycythemia Vera

January 11th 2024

This article was sponsored by PharmaEssentia.

Current and Emerging Therapeutic Advances in Follicular Lymphoma

October 23rd 2023

Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia: Where are we in 2023?

July 19th 2023

Therapeutic Considerations Across the Disease Continuum of HER2+ Breast Cancer

June 9th 2023

Bridging Current Practices and New Therapeutic Developments in Breast Cancer

June 8th 2023

Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice

April 19th 2023

Clinical Decision Making in Advanced NSCLC without Actionable Mutations

March 16th 2023

BTK Inhibitors in MCL and CLL

March 10th 2023

OncLive Data Review: SABCS 2021

March 2nd 2023

OncLive® Clinical Updates: Cardiovascular Adverse Events with BTK Inhibitors in B Cell Malignancies

February 9th 2023

Where Do ADCs Fit Into the Treatment Paradigm for Patients With NSCLC?

January 24th 2023

Clinical Case Scenarios: Approaches to Treatment Decisions in Non-Small Cell Lung Cancer

January 24th 2023

Updates and Advances in Esophageal Squamous Cell Carcinoma (ESCC)

January 17th 2023

Updates in the Management of Small-Cell Lung Cancer in the Second-Line and Beyond

January 13th 2023

Evidence-based Management of Breast Cancer: Updates From SABCS

January 6th 2023

Recent Updates in Molecular Targets and Pathways in Lung Cancer

December 16th 2022

Sponsored by Daiichi Sankyo. Content independently developed by OncLive®.

Uncommon Mutations in NSCLC

December 12th 2022

Best Practices on Addressing Disparities and Practicing Multicultural Care in Myeloma

December 12th 2022

Exploring Recent Updates in the Treatment of Breast Cancer

November 16th 2022